Connect with us
Grifols secured a $21 million grant from the Michael J. Fox Foundation to study plasma biomarkers for early Parkinson’s detection. The 10-year Chronos PD project will...
The biotech industry thrived during the pandemic, fueled by vaccine demand, but post-2022 saw capital declines. In 2024, capital increases reached €999 million, led by Qiagen...
German biotech financing surged 78% in 2024, totalling €1.92 billion, driven by venture capital (€898 million), public market funding (€999 million), and an IPO. Notable deals...
Global markets saw mixed performances: DAX fell 0.6% to 19,909 points, pressured by BASF, BMW, and Bayer. MDAX and TecDAX also dropped. Hang Seng gained 0.7%,...
In 2024, Spanish pharma focused on stabilizing finances rather than expanding, with six major players seeing an 18% profit drop compared to 2023. While Faes Farma...
Zerintia HealthTech, a Spanish digital health firm, expands into Saudi Arabia and the UAE with its 4RemoteHealth platform, enabling real-time remote collaboration in complex medical settings....
Grifols faced a turbulent 2024 with leadership changes, legal battles, and debt refinancing. Accusations by Gotham City Research and a rejected takeover bid from Brookfield added...
Novartis plans to sell Morphosys' business, acquired for €2.7 billion in 2023, affecting 330 employees as it closes two factories by 2025. Initially aimed at boosting...
Novo Nordisk completed the €10.66 billion acquisition of Catalent, including three production plants to scale up Wegovy production. Despite rivals' opposition, the deal secures Novo’s market...
Roche's CE Mark-approved cobas Mass Spec offers automated, standardized mass spectrometry for over 60 tests, improving care for breast cancer and hormonal therapy patients. It aids...